Increased neuropil antibody prevalence in COVID-19 patients with acute ischemic stroke

CONCLUSION: Our results confirm the presence of neuropil antibodies in patients with COVID-19 infection and identify a putative antibody-driven association between AIS and COVID-19. The antigenic targets and potential pathogenic action of these antibodies need to be further explored.PMID:37634189 | DOI:10.1080/01616412.2023.2252282
Source: Neurological Research - Category: Neurology Authors: Source Type: research